Discover 3,498 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,498
PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)
for
Rheumatoid Arthritis
Location: Whittier CA
Sponsor: Scipher Medicine
Sex: All
Age: 18 - 70+
Code: NCT06390709
Recruiting
A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants
for
Healthy Male Adults, Food Effect in Healthy Volunteers
Location: Los Alamitos CA
Sponsor: AnnJi Pharmaceutical Co., Ltd.
Sex: Male
Age: 18 - 55
Code: NCT07549919
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Los Alamitos CA, Beverly Hills CA, Los Angeles CA,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase 3, Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Los Angeles CA, Dallas TX, Omaha NE, Kansas City KS,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06710756
Phase 1, Phase 2, Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
for
Lymphoid Malignancies
Location: Los Angeles CA, Whittier CA, Duarte CA, Dallas TX,
Sponsor: AVM Biotechnology Inc
Sex: All
Age: 12 - 70+
Code: NCT04329728
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
for
Advanced Unresectable Gastric Adenocarcinoma,
Location: Los Angeles CA, Cerritos CA, St Louis MO, Canton OH,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07554521
Phase 2, Recruiting
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
for
Bladder Carcinoma, Genitourinary System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05519878
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, Glendale CA, Anaheim CA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT06629779
Phase 3, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Orange CA, San Dimas CA, Tustin CA, Santa Clarita CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase 3, Recruiting
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
for
Opioid Use Disorder
Location: Colton CA
Sponsor: RAND
Sex: All
Age: 18+
Code: NCT06827288
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Location: Los Angeles CA, Chicago IL, Ann Arbor MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06401356
Phase 3, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Burbank CA, Phoenix AZ, Reno NV, Grand Junction CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06170788
Phase 3, Recruiting
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Duarte CA, Ann Arbor MI, Columbus OH, Durham NC
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT04858256
Phase 2, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Los Angeles CA, Beverly Hills CA, Fountain Valley CA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
Vocal Emotion Communication With Cochlear Implants
for
Cochlear Hearing Loss
Location: Los Angeles CA, Tempe AZ, Omaha NE
Sponsor: Father Flanagan's Boys' Home
Sex: All
Age: 6 - 70+
Code: NCT05486637
Early Phase 1, Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: Los Angeles CA, Orange CA, Stanford CA, Phoenix AZ,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase 3, Recruiting
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Dallas TX, Houston TX, Ann Arbor MI,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05941507
Phase 1, Phase 2, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)